Adi Mohanty
Chief Executive Officer at BIORA THERAPEUTICS, INC.
Net worth: 97 752 $ as of 29/04/2024
Adi Mohanty active positions
Companies | Position | Start | End |
---|---|---|---|
BIORA THERAPEUTICS, INC. | Director/Board Member | 07/11/2021 | - |
Chief Executive Officer | 07/11/2021 | - | |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | Director/Board Member | - | - |
Career history of Adi Mohanty
Former positions of Adi Mohanty
Companies | Position | Start | End |
---|---|---|---|
EnCellX, Inc.
EnCellX, Inc. BiotechnologyHealth Technology EnCellX, Inc. is a biotechnology company that operates in the field of biotechnology. The private company is based in San-Diego, CA and has subsidiaries in Israel. The company was founded by Aditya P. Mohanty. | Chief Executive Officer | 30/11/2019 | 31/10/2021 |
Founder | 30/11/2019 | 31/10/2021 | |
ONCOCYTE CORPORATION | Director/Board Member | 31/03/2015 | 16/06/2020 |
LINEAGE CELL THERAPEUTICS, INC. | Director/Board Member | 27/02/2016 | 16/09/2018 |
Chief Executive Officer | 14/10/2015 | 16/09/2018 | |
Chief Operating Officer | 28/12/2014 | 14/10/2015 | |
President | 28/12/2014 | 16/09/2018 | |
ASTERIAS BIOTHERAPEUTICS INC | Director/Board Member | 08/06/2015 | 07/03/2018 |
SHIRE | Corporate Officer/Principal | 31/12/2004 | 31/12/2013 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Corporate Officer/Principal | 31/12/2001 | 31/12/2004 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 31/12/2001 | 31/12/2004 |
Training of Adi Mohanty
St. Mary's College (Indiana) | Masters Business Admin |
Clarkson University | Graduate Degree |
National Institute of Technology Tiruchirappalli | Undergraduate Degree |
Statistics
International
United States | 10 |
India | 2 |
Ireland | 2 |
Operational
Director/Board Member | 5 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 3 |
Sectoral
Health Technology | 8 |
Consumer Services | 4 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
ONCOCYTE CORPORATION | Health Technology |
BIORA THERAPEUTICS, INC. | Health Services |
Private companies | 6 |
---|---|
Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
EnCellX, Inc.
EnCellX, Inc. BiotechnologyHealth Technology EnCellX, Inc. is a biotechnology company that operates in the field of biotechnology. The private company is based in San-Diego, CA and has subsidiaries in Israel. The company was founded by Aditya P. Mohanty. | Health Technology |
- Stock Market
- Insiders
- Adi Mohanty
- Experience